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Gene fusions were constructed between Ste2, the receptor for the Saccharomyces cerevisiae a-factor, and lIa,
the secreted form of P-lactamase encoded by the bla gene of pBR322. The Ste2 and fla components were linked
by a processing fragment (P) from the yeast killer preprotoxin containing a C-terminal lysine-arginine site for
cleavage by the Golgi-associated Kex2 protease. Ste2 is predicted to have a rhodopsinlike topology, with an
external N terminus and seven transmembrane segments. Fusions to three of the four Ste2 domains predicted
to be external resulted in ,la secretion from yeast cells. A fusion at a site just preceding the first transmembrane
segment was an exception; the product was ceUl associated, indicating that the first 44 residues of Ste2 are
insufficient to direct secretion of DIa; translocation of this domain presumably requires the downstream
transmembrane segment. Expression of fusions located in two domains predicted to be cytoplasmic failed to
result in Pla secretion. Following insertion of the preprotoxin signal peptide (S) between the Ste2 and P
components of these cytoplasmic fusions, secretion of (la activity occurred, which is consistent with inversion
of the orientation of the Pla reporter. Conversely, insertion of S between Ste2 and P in an external fusion
sharply reduced (la secretion. Complementary information about both cytoplasmic and external domains of
Ste2 was therefore provided, and most aspects of the predicted topology were confirmed. The steady-state levels
of (la detected were low, presumably because of efficient degradation of the fusions in the secretory pathway;
levels, however, were easily detectable. This method should be valuable in the analysis of in vivo topologies of
both homologous and foreign plasma membrane proteins expressed in yeast cells.
The use of fusions of N-terminal fragments of a target
protein to a C-terminal reporter has proved to be one of the
more successful in vivo expression techniques for analyzing
membrane insertion topologies of transmembrane proteins in
Escherichia coli. Its utility was first demonstrated by Manoil
and Beckwith (27), who constructed a series of gene fusions
between E. coli Tsr, an integral membrane protein, and the
normally secreted enzyme alkaline phosphatase (PhoA);
bacteria containing such fusion proteins expressed high
levels of alkaline phosphatase activity only if the site of
fusion was located in a domain of Tsr predicted to be
periplasmic. Fusions located in putative cytoplasmic do-
mains of Tsr exhibited little or no alkaline phosphatase
activity. The gene fusion method has since been used in the
topological analysis of several E. coli membrane proteins,
and 3-galactosidase (lacZ; 17, 26) has been used as a
cytoplasmically active reporter complementary to PhoA.
The ,-lactamase product of the bla gene of pBR322 is an
especially useful reporter in E. coli, since it is capable of
positively identifying both external and cytoplasmic fusion
sites (8). The results are usually interpreted on the basis of
the signal/stop-transfer hypothesis of membrane protein
insertion (3, 16). This hypothesis assumes that the two-
dimensional topology in polytopic transmembrane proteins
is determined by the sequential and alternate insertion of
each membrane-spanning segment as either a signal peptide
(C terminus outside) or a stop-transfer region (C terminus
inside) without reference to downstream sequence. The
validity of this interpretation is enhanced if both internal and
external fusion sites are positively identified and the result-
ing topological model is internally consistent.
* Corresponding author.
Although several Saccharomyces cerevisiae membrane
proteins have been cloned and their topologies have been
predicted from the genomic sequence (11, 12, 19, 29, 34, 36),
only one, 3-hydroxy-3-methylglutaryl coenzyme A reduc-
tase, which is located in the endoplasmic reticulum (ER), has
so far proved amenable to thorough in vivo topological
analysis by gene fusion (33). Successful applications of gene
fusion techniques to topological analysis of yeast plasma
membrane proteins have so far been limited to in vivo
analysis of the most C-terminal segment of the Ste3 a-factor
receptor (12) and in vitro expression systems (1, 20). Not-
withstanding the utility of such studies, a broadly applicable
in vivo approach would, in addition to avoiding artifactual
problems associated with in vitro systems, be more rapid
and flexible. The present paper describes such a system
employing a modification of the target-reporter gene fusion
technique to allow processing and secretion of the reporter.
Ste2, the product of the STE2 gene, an integral plasma
membrane protein that is the receptor for the yeast a-factor
mating pheromone, was the target protein chosen for this
study. Its predicted topology is homologous to that of the
bacteriorhodopsin class of membrane receptors, containing
seven clearly predictable transmembrane segments, and it
couples to a homologous G protein (Fig. 1; 9, 29). The
cytoplasmic location of the C-terminal domain of Ste2 is
implied by the a-factor-dependent degree of phosphorylation
occurring within this domain (31). The deduced orientation
of the N terminus is external (Fig. 1), as in rhodopsin and all
G protein-coupled receptors of this type, even though this
N-terminal sequence is not preceded by and does not contain
a recognizable signal sequence.
We have previously demonstrated that Pla, the mature
,-lactamase encoded by the bla gene of pBR322, is effi-
ciently secreted from yeast cells when it is expressed from a
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FIG. 1. Proposed topology of Ste2 and sites
The external N terminus, seven predicted
and the cytoplasmic C terminus are shown.
sites, at the HpaI, Dral, NsiI, Styl,ClaI, PstI
The sequences resulting from fusion at Val-44, Phe-98,
Leu-235, Ser-259, and Ala-369 to P-lla in pSte2-PxB
shown at the bottom. The Pstl linkers inserted
ppTox during construction result in the insertion
residues between Ste2 and P-pla, as indicated
yeast promoter and preceded by a yeast (S)
and an intervening processing region (P)
preprotoxin, ppTox (6, 10). Pla is attached
of P at a site for cleavage by the Kex2 endopeptidase
28), so that processing in the Golgi leads Pla
modified by the N-terminal addition of aspartyl-prolyl-
glycyl tripeptide.,la functions as a monomer,
N-glycosylation sites, and is completely
supernatants of yeast cells grown on appropriately
media (10). Moreover, Pla remains active
cells when fused to the C termini of
secreted peptides or when cytoplasmically
39). Since a modified colorimetric assay
tection of Pla at the picogram level (10),
direct C-terminal fusions to Pla would
analysis of yeast plasma membrane
when such direct fusions to Ste2 were
cells, we could not detect the products
disrupted the normal Ste2 topology. Destruction
membrane proteins in the ER of mammalian
documented (2, 30, 38), and such mechanisms
tainly exist in yeast cells, where many components
salvage pathway have been identified
Hoping that at least part of this destruction
post-Golgi event involving targeting to
modified our approach by constructing
fusions between Ste2 and Pla bridged by
ppTox fragment P. Indeed, expression Ste2-,la
bridged by this fragment led to production Pla.
Fusions at sites predicted to be extracellular
creted Pla activity, whereas fusions at
cytoplasmic yieldedla activity that
with cells. Moreover, insertion of
tion signal, between the Ste2 and P components
cytoplasmic fusions resulted in secretion of Pla activity.
Thus, reciprocal information about periplasmic and cyto-
plasmic domains of Ste2 was obtained, and an internally
consistent topology that agreed with predictions was de-
rived.
MATERIALS AND METHODS
Strains and media. E. coli AKEC 28 (24) was used for
plasmid selection and propogation. S. cerevisiae DJ213-7-3
(MATa ste2-JO::LEU2 ura3 bar)-) cry] ade2 his4-580 lys2
trpl tyrl sup4-3ts) and DJ240-8-3 (stp22-7 BAR), otherwise
isogenic to DJ213-7-3), both obtained from Duane Jenness,
were the standard host strains used to test expression of
Ste2-Pla fusions. Strain BFY113 (MATa kex2::TRPJ can)
his3 leu2 trpl ura3 ade2), obtained from Robert Fuller, was
used to demonstrate Kex2-dependent cleavage of fusion
proteins. Restoration of Kex2 function to BFY113 was
achieved by transformation with the plasmid pKEX2-H, a
YEp6 derivative containing HIS3 and the KEX2 coding
region and promoter (39). pKEX2-T is a derivative carrying
the TRPI gene (39). Transformants of strains containing
fusion protein expression plasmids were selected by uracil
prototrophy and maintained on synthetic complete medium
lacking uracil (35).
Construction of p2OSPnB and p2OSPxB expression vectors
and of direct Ste2-I1a fusions. p2OTB is a derivative of
YEp352 (a pUC derivative carrying the2,um origin and the
URA3 gene; 22) with an expression cassette (Fig. 2A)
inserted at its multiple cloning site. This cassette consists of
promoter and terminator fragments of the PGK gene flanking
a fusion of T, a DNA fragment encoding the first 233 residues
of K1 preprotoxin (ppTox; 6), to B, a DNA fragment
encoding Pla (10). Pla is the mature sequence of P-lactamase
preceded by an Asp-Pro-Gly tripeptide (Fig. 2B, i). The C
terminus of T is the Lys Arg-233 site for cleavage by the
Kex2 endopeptidase. Cleavage at this site during expression
ofp20TB results in secretion of,Bla (10). p2OSPB (Fig. 2B, i)
is identical to p20TB except that the PstI-to-AccI fragment
encompassing codons 35 to 176 of ppTox is deleted and an
in-frame PstI linker is inserted, leaving the S (signal) and P
(processing) ppTox fragments separated by a single alanine
residue (10). The sequences of S and P are shown in Fig. 2G.
Insertion of an XhoI linker at the BstEII site of p20SPB
produced the xB fragment in p20SPxB;ila is changed to
xpla, and its N terminus is changed to Asp Pro Gly His Asn
Ser Ser Cys (Fig. 2B, ii). The Asn Ser Ser N-glycosylation
site was introduced to provide an additional indicator of Pla
secretion. Insertion of an NsiI linker at the same BstEII site
in p2OSPB produced p2OSPnB (Fig. 2B, iii). The P-pla fusion
is no longer in frame, but insertion of Ste2 fragments in place
of P produced direct Ste2-Pla fusions (Fig. 2E).
Construction of Ste2-nB (direct) and Ste2-PxB fusions. The
entire coding sequence of the STE2 gene, as a 1.7-kb HindIII
fragment derived from pWS2 (obtained from D. Jenness),
was inserted into theHindIll site of the plasmid YEpDT-
GAL (24), producing pDTGSte2 (Fig. 2D). The 8-bp PstI
linker 5' GCTGCAGC 3' was introduced at the HpaI, DraI,
and Clal sites in the STE2 segment of pDTGSte2 after blunt
ends were created, if necessary, with the Klenow fragment
ofDNA polymerase I. The 12-bp Pstl linker 5' CGGCTGCA
GCCG 3' was similarly introduced into the STE2 StyI site.
Plasmids pDTGSte2(Pst-44), pDTGSte2(Pst-98), pDTGSte2
(Pst-235), and pDTGSte2(Pst-259) were thus generated.
STE2 contains one Pstl and two Nsil sites (Fig. 2D); these
sites and all of the PstI sites introduced into STE2 are in the
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MEMBRANE PROTEIN TOPOLOGY IN YEAST CELLS
same reading frame. An EcoRI site immediately flanks the
N-terminal STE2 HindIII site in these constructions; N-ter-
minal EcoRI-Nsil or EcoRI-PstI Ste2 fragments of variable
length, from pDTGSte2 or its derivatives, were inserted into
p2OSPnB, giving direct Ste2-pla fusions (pSte2-nB; Fig. 2E).
Insertion into p2OSPxB (Fig. 2B, ii) gave fusions pSte2-44-
PxB, etc. (Fig. 2F). Each construct was numbered according
to the Ste2 codon at the fusion site. Sequences at the fusion
sites were determined by using the primer (5') CC GCT GTT
GAG ATC CAG, complementary to codons 24 to 29 of
mature 13-lactamase. All sequences were as predicted. The
position of each Ste2-PxB fusion within the framework of the
proposed Ste2 topology and the sequence at each fusion site
are shown in Fig. 1. A variable number of Ala residues
derived from the PstI linkers employed were inserted be-
tween Ste2 and P.
Construction of Ste2-SPB fusions. An XhoI linker (5'
CCTCGAGG 3') was inserted into the EcoRl site (blunted
with mung bean exonuclease) located at the 3' end of pPGK
in p2OSPB (Fig. 2B). A second linker (PstI; 5' GCTGCAGC
3') was inserted into this XhoI site after filling with the
Klenow polymerase I fragment, producing p21SPB (Fig.
2C). An open reading frame from this PstI site overlaps the
N terminus of the ppTox signal after five codons (Ala Ala
Arg Gly Asn MET; Fig. 2G). The SPB fragment was excised
from p21SPB by partial PstI digestion followed by complete
digestion with BgIII and was used to replace the (PstI-to-
BgIII) PxB fragment in plasmids pSte2-98-PxB, pSte2-235-
PxB, and pSte2-369-PxB, producing the equivalent pSte2-
SPB fusions (Fig. 2G).
Preparation of cell extracts and assay of I-lactamase activ-
ity. Cells were harvested from late-exponential-phase cul-
tures (2 x 107 to 4 x 107 cells per ml) growing in SC-Ura
medium buffered with 100 mM NaPO4 (pH 6.8). 3-Lacta-
mase is stabilized in culture supernatants above pH 5.5. Cell
extracts were prepared, and 1-lactamase activities in sam-
ples (20 ,ul) of culture supernatants and cell extracts were
determined by using a microtiter plate assay (10). The limits
of detection in unconcentrated culture media and in solubi-
lized whole-cell extracts corresponded to 40 and 5 pg of
P-lactamase per 106 cells, respectively.
Immunoblotting. Proteins (50 to 100 p.g total) in yeast cell
extracts were denatured by heating them in gel loading buffer
(0.5 M Tris, 20% [vol/vol] glycerol, 1% [wt/vol] sodium
dodecyl sulfate, 1% [vol/vol] 3-mercaptoethanol; pH 6.8) for
30 min at 37°C and then separated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis. After electro-
phoresis, proteins were transferred to nitrocellulose mem-
branes, and after incubation with immunoadsorbed rabbit
anti-p-lactamase antisera (5 Prime-3 Prime Inc., West
Chester, Pa.), Ste2-,la fusion proteins were detected by
incubation with 125I-labeled protein A (0.1 mCi/ml; NEN
Research Products, Boston, Mass.) followed by autoradiog-
raphy.
RESULTS
Activity of direct Ste2-pla fusions. In transformants of
strain DJ213-7-3 expressing pSte2-369-nB, a direct ,la fu-
sion (Fig. 2E) within the presumptively cytoplasmic C ter-
minus of Ste2, we were able to detect cell-associated 13-lac-
tamase activity at a level of 1 to 2 ng/107 cells and a weak
signal in Western blots (immunoblots) for a fusion protein of
the expected size (data not shown). However, we were
unable to detect either activity or immunoreactive protein in
cell extracts or membrane preparations from cells of the
same strain expressing the equivalent Ste2-98 or Ste2-206
direct fusions. We surmised that any Ste2 fusion lacking
parts of its transmembrane segments was being efficiently
retained in the ER and destroyed by surveillance systems for
aberrant membrane proteins. It also seemed likely that any
fraction of the fusion proteins escaping the salvage mecha-
nism and reaching the Golgi was being targeted directly to
the vacuole or suffered endocytosis and vacuolar destruction
rather than accumulating on the cell surface. We therefore
inserted P, containing a C-terminal Kex2 processing site,
between the target and reporter in the hope of rescuing the
ila reporter component of any fraction of the fusion proteins
reaching the Golgi compartment where Kex2 is active (18,
23, 28). P incorporates codons 177 to 233 of the yeast K1
killer preprotoxin (ppTox; 6, 10) and contains three N-gly-
cosylation sites and a second internal potential Kex2 proc-
essing site (Fig. 2G; 39). We also inserted an N-glycosylation
site at the N terminus of the Pla reporter, changing it to xpla;
core N glycosylation of secreted x,la occurs at this site with
reasonable efficiency (50 to 60%o); this has no detectable
effect on either the efficiency of secretion or the activity or
stability of xpla in culture supernatants (10). The modified
fusion constructs are called pSte2-PxB (Fig. 2F).
Activity and subcellular location of P-lactamase components
of Ste2-PxB fusions. We predicted that Ste2-PxB fusions
which reach the Golgi anchored to the lumenal face of the
membrane by their Ste2 component would be processed to
release secreted P-lactamase, while those fusions anchored
to the cytoplasmic face would not. This is schematically
represented for the Ste2-98-PxB (lumenal) and Ste2-235-
PxB (cytoplasmic) fusions in Fig. 3A and C, respectively.
P-Lactamase activities of transformants containing the var-
ious pSte2-PxB fusion plasmids are shown in Table 1. In the
wild-type tester strain DJ213-7-3, only cells transformed by
FIG. 2. Construction of Ste2-,Bla fusions. All of the expression cassettes shown were inserted into the multiple cloning site of YEp352 (22)
and are flanked by the PGK promoter and terminator fragments shown in p2OTB. Ste2 segments (dark stippling) and the Ila and x,Bla reporters
(light stippling) are indicated. (A) p20TB. The PGK expression cassette encompasses T, the first 233 codons of K1 preprotoxin (ppTox), fused
at its KR-233 site to B, the BamHI-to-BglII fragment which encodes Pla. (B) i, p2OSPB, produced from p2OTB by insertion of a PstI linker
at the AccI site in T followed by deletion of the PstI fragment internal to ppTox. ii, p2OSPxB, the product of insertion of the XhoI linker
AACTCGAGTT at the filled-in BstEII site of p2OSPB. The N-terminal extensions of the Pla and xpla reporters (DPG and DPGHNSSC,
respectively), produced by Kex2 cleavage, are illustrated. iii, p2OSPnB, the product of insertion of the NsiI linker TGCACTAGTGCA at the
filled-in BstEII site of p2OSPB. (C) p21SPB, produced from p2OSPB by sequential insertion of XhoI and PstI linkers at the EcoRI site. (D)
pDTGSte2, constructed by insertion of the HindIII fragment encoding STE2 from pWS2 into pDTGAL (24). The sites at which PstI sites were
introduced (Fig. 1) are indicated. (E) Direct Ste2-Pla fusions resulting from insertion of EcoRI-PstI or EcoRI-Nsil fragments from pDTGSte2
into p2OSPnB cut with EcoRI and NslI. (F) Ste2-PxB fusions resulting from insertion of the same fragments from pDTGSte2 into p2OSPxB
cut with EcoRI and partially cut with PstI. (G) Ste2-SPB fusions. The PstI-BgIII fragment encompassing PxB in the Ste2-PxB fusions was
replaced with the PstI-BglIl fragment of p21SPB encompassing SPB. Amino acid sequences of the S and P fragments are shown below in
standard one-letter code. Kex2 cleavage sites and N-glycosylation sites are shown in boldface type.
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FIG. 3. Schematic representations of fusion product topologies and potential Golgi processing. The PxB and PB reporters are shown as
P-KR-xpla and P-KR-ala, where KR represents the Kex2 cleavage site at the C terminus of P. The Kex2 protease is represented as a
membrane-anchored enzyme with its active site directed towards the lumen. (A) Ste2-98-PxB fusion, illustrating potential release of secreted
x,Bla by Kex2 cleavage. (B) Ste2-98-SPB fusion, illustrating how S, by acting as a stop-transfer sequence, may render the PB reporter
cytoplasmic. (C) Ste2-235-PxB fusion, illustrating the cytoplasmic location of the reporter. (D) Ste2-235-SPB fusion, illustrating how S, by
acting as a signal, exposes the reporter to Kex2, leading to 1la secretion.
construct Ste2-98-PxB, Ste2-206-PxB, or Ste2-259-PxB se-
creted amounts of 13la detectable by activity assay. The site
of fusion between Ste2 and PxB in each of these constructs
is predicted to be just prior to or within an external loop (Fig.
1). Transformants containing the three remaining Ste2-PxB
fusion protein constructs failed to secrete Pla (Table 1).
According to the topological model of Ste2, the fusion
sites of Ste2-235-PxB and Ste2-369-PxB should be cytoplas-
mic, while the fusion site of Ste2-44-PxB should be external.
However, the N-terminal domain of Ste2 up to Val-48 does
not contain a recognizable signal sequence. Translocation of
this region of the protein into the lumen of the ER, therefore,
is presumably dependent on insertion of at least the first
membrane-spanning segment of Ste2 into the ER membrane
(15, 16). In the absence of the first membrane-spanning
segment, membrane association and translocation of the
Ste2-44-PxB fusion protein would not be predicted, suggest-
ing that this fusion protein should remain cytoplasmic and
therefore cell associated, as we found. These results, there-
fore, are entirely consistent with the topology predicted for
Ste2 based on hydropathy analysis and analogy to bacteri-
orhodopsin (Fig. 1; 9).
Effect of an stp22-7 mutation on expression of Ste2--
lactamase fusions. Expression of p20SPxB, in which the Ste2
component of the Ste2-PxB fusions is replaced with the
ppTox signal (Fig. 2B), resulted in efficient processing and
about 90% secretion of pla at a level 50-fold higher than the
highest level seen for any Ste2 fusion (Table 1). Expression
of p2OSPB gives the same high level of ,1la secretion (10). It
seems apparent, therefore, that the translational efficiency of
the Ste2 fusions is low, that Kex2 processing of these fusions
is inefficient, or that most of the fusion protein is being
destroyed prior to Kex2 processing in the Golgi. Cotransfor-
mation of Ste2-206-PxB transformants of strain DJ213-7-3
with pKEX2-T, which should increase the expression level
of Kex2 severalfold above that of wild type, failed to
enhance 1la expression (not shown), suggesting that Kex2
activity does not limit the efficiency of Pla secretion. Ste2 is
normally expressed from its own promoter in MATa cells to
give about 10,000 functional copies per cell, suggesting that
its normal transcript is well translated (25). Thus, destruc-
tion of the fusion proteins in the ER seems the most likely
cause of low yield. The level of expression of functional Ste2
receptors has not been observed to increase proportionally
with gene copy number (25), suggesting that correct mem-
brane insertion may be rate limiting, even for the normal
protein.
We tested the effect of the stp22-7 mutation on expression
levels of Ste2-Pla fusion proteins. This mutation was isolated
as a suppressor of the ste2-3ts mutation and allows enhanced
expression not only of this missense mutant of STE2 but also
of other plasma membrane proteins carrying temperature-
sensitive mutations (22a). Transformants of strain DJ240-8-3
(stp22-7, otherwise isogenic to DJ213-7-3) containing con-
struct Ste2-206-PxB or Ste2-259-PxB expressed levels of
total Ila activity 40 to 50% higher than those of comparable
transformants of DJ213-7-3 (Table 1). Since a disproportion-
ate fraction of this increase in activity was secreted, an
approximately threefold increase in secreted activity was
observed. The normal STP22 gene product may increase the
proportion of aberrant, membrane-associated proteins de-
stroyed in the ER. The amount of Ila activity produced by
fusion Ste2-98-PxB was relatively high and was little af-
fected by the stp22-7 mutation. This suggests either that
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MEMBRANE PROTEIN TOPOLOGY IN YEAST CELLS
TABLE 1. 1-Lactamase activities produced by transformants
containing Ste2-PxB fusions
,B-Lactamase activityb
Fusion Yeast straina Cell
Secreted associated Totalc
YEp24 DJ213-7-3 <40 <5
Ste2-44-PxB DJ240-8-3 <40 129 129
DJ213-7-3 <40 169 169
BFY113 <40 126 126
Ste2-98-PxB DJ240-8-3 487 255 742
DJ213-7-3 468 173 641
BFY113 114 52 166
BFY113+ 392 197 589
YEpKEX2d
Ste2-206-PxB DJ240-8-3 249 234 583
DJ213-7-3 89 285 374
BFY113 <40 50 50
Ste2-235-PxB DJ240-8-3 <40 95 95
DJ213-7-3 <40 66 66
BFY113 <40 26 26
Ste2-259-PxB DJ240-8-3 141 193 334
DJ213-7-3 53 185 238
BFY113 <40 56 56
Ste2-369-PxB DJ240-8-3 <40 450 450
DJ213-7-3 <40 115 115
BFY113 <40 129 129
p2OSPxB' DJ213-7-3 40,800 3,510 44,310
BFY113 5,140 8,600 13,740
a Strains were DJ213-7-3 (STP22), DJ240-8-3 (stp22), and BFY113 (STP22
kex2).
b All enzyme activities are in picograms of P-lactamase per 106 organisms
and are means of three replicate determinations carried out on at least two
independent transformants. A value of <40 indicates that ,3-lactamase activity
was below the level detectable in unconcentrated culture supernatants. The
minimum detectable level of cell-associated ,-lactamase activity is approxi-
mately 5 pg/106 organisms. The levels produced by a YEp shuttle plasmid
carrying the normal bla gene, such as YEp24, were undetectable by these
assays.
c The sums of activities detected in culture supernatants and cell extracts.
d This plasmid restores a near-normal level of KEX2 expression (39).
e These control transformants express the reporter with no Ste2 N-terminal
fragment.
there is insufficient Ste2 protein in this severely truncated
fusion for recognition by the STP22-dependent component
of the surveillance mechanism or that because of its struc-
tural simplicity, misinsertional or misfolding events involv-
ing the Ste2-98-PxB protein are comparatively infrequent.
DJ240-8-3 (stp22) transformants containing presumptively
cytoplasmic fusion constructs, i.e., Ste2-44-PxB, Ste2-235-
PxB, and Ste2-369-PxB, like their STP22 counterparts,
failed to secrete detectable amounts of Pla, although a
significant increase in cell-associated activity was observed
with the last construct (Table 1). The data obtained with
strain DJ240-8-3, therefore, confirm those obtained with the
STP22 strain.
Effect of Kex2 on 1-lactamase activity of Ste2-131a fusions.
Strain BFY113 contains a null mutation in KEX2. Analyses
of expression of p2OSPxB and related Pla fusions in this
strain demonstrated that apparent Kex2 processing still
occurred at 10 to 15% of the level seen in a KEX2 strain
(Table 1; 39). Similar results have been reported for proc-
essing of yeast prepropheromones in kex2 strains (14, 23),
probably because of the presence of a similar enzyme
encoded by YAP3 (14). Secreted jla activities of BFY113
transformants of the Ste2-98-PxB fusion were approxi-
mately 25% of those of the DJ213-7-3 transformants, and
secretion from the 206 and 259 fusions dropped below
detectable levels in this strain, demonstrating that, as ex-
pected, Kex2-dependent cleavage is primarily responsible
for liberation of Pla from these fusion proteins. Since cell-
associated 1la activities produced by BFY113 transformants
containing these fusions were also decreased by 70 to 80%o,
these cell-associated activities probably also reflect Kex2-
processed ,la rather than unprocessed, membrane-bound
fusion protein. The time required for Pla to reach the
medium in cells expressing p2OSPB is fairly long (about 20
min at 30°C), and a significant fraction of the cell-associated
activity is associated with the cell walls (10). This may
explain why the fraction of processed ,la remaining cell
associated increases at lower expression levels (Table 1).
Cotransforming BFY113 with Ste2-98-PxB and pKEX2-H
elevated the level of activity to that observed in transfor-
mants of strain DJ213-7-3 (Table 1), showing that the differ-
ence in ila activity observed between BFY113 and DJ213-
7-3 is due to KEX2 activity. With the exception of the
activity of the Ste2-235-PxB fusion, levels of cell-associated
activity of the presumptively cytoplasmic fusions were un-
affected by the kex2 mutation (Table 1). Since the Ste2-44-
PxB fusion is apparently cytoplasmic and the Ste2-369-PxB
fusion is correctly folded (see below), it was not surprising
that their expression levels were unaffected. Perhaps a small
fraction of the cell-associated Pla activity of the Ste2-235-
PxB fusion results from improper membrane insertion
events leading to Ste2-1la molecules that can be cleaved by
Kex2. If so, total Pla activity could be enhanced by the stp22
mutation, while the level secreted would still be too low to
be detectable in culture supernatants.
Receptor activity of fusion proteins. All transformants
containing Ste2-PxB fusion constructs have a ste2 back-
ground and were tested for expression of functional Ste2
derived from the plasmids by use of the zone assay for
a-factor sensitivity (24). Activity was detected only for
Ste2-369-PxB. Assuming the specific activity of the Pla
component of the fusion protein to be equal to that of free
Pla, the expression level of Ste2-369-PxB in strain DJ240-8-3
(stp22-7) is 2,000 to 3,000 cell-1, approximately 20 to 30% of
the wild-type level of Ste2 (25). As expected if a receptor of
normal function were expressed at this reduced level, these
transformants gave a near-normal response to a-factor, as
judged by zone size and clarity (Fig. 4). Use of heavier
inocula produced turbid zones, indicating a response weaker
than that of wild type (not shown). DJ213-7-3 (STP22)
transformants containing the Ste2-369-PxB fusion gave no
response to a-factor, presumably reflecting the threefold-
lower expression level of the Ste2-369-PxB fusion protein
seen in this strain.
Immunoblotting of Ste2-PxB fusion proteins. Since cell
extracts obtained from Ste2-44-PxB and Ste2-369-PxB
transformants contained Ila activities that were not affected
by a kex2-null mutation, it was anticipated that these activ-
ities would reflect the activities of intact fusion proteins. The
content and gel mobility of Ste2-P-Pla proteins present in
transformants containing these plasmids were therefore de-
termined by immunoblotting. The predominant immunore-
active species in transformants containing Ste2-369-PxB
was an approximately 80-kDa protein corresponding to the
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FIG. 4. Response of transformants containing the Ste2-369-PxB
fusion to a-factor. (A) Strain DJ240-8-3 (MATa stp22 ura3) trans-
formed with pSte2-369-PxB. (B) Strain DJ147-1-2 (MATa STP22
ura3) transformed with pPGK (24) to give a URA3 phenotype.
SC-Ura agar (5 ml) was seeded with 2 x 10' organisms and poured
onto an SC-Ura plate, and sterile disks containing 8.5, 2.1, 0.5, or
0.1 ,ug of synthetic a-factor (counterclockwise from the top) were
placed on top of the overlay. Plates were incubated for 48 h at 30°C.
expected size of the unprocessed Ste2-369-PxB fusion pro-
tein (Fig. 5, lane 2). The observed receptor function of this
fusion protein indicates that it is correctly inserted into and
folded within the ER membrane and is subsequently local-
ized to the plasma membrane. Some smaller-sized species
were also present in Ste2-369-PxB-containing extracts, in-
cluding a species with approximately the same mobility as
mature-length ,-lactamase (29 kDa). These lower-molecular-
mass species probably arise as a result of proteolysis occur-
ring during secretion, turnover, or cell lysis. The predom-
inance of the mature-length P-lactamase species probably
indicates that this fragment of the fusion protein, like P-lac-
tamase itself, is relatively resistant to further degradation.
The amount of Ste2-369-PxB fusion protein present in cell
extracts, estimated from the strength of the Western blot
signal (Fig. 5), correlated well with that predicted from jla
1 2 3
95
~I_
55
43
36
29-
FIG. 5. Immunoblot of Ste2-PxB fusion proteins. Lane 1, P-lac-
tamase standard (50 ng of protein, purified as described previously;
10); lane 2, cell extract from strain DJ240-8-3 (MATa stp22 ura3)
transformed with Ste2-369-PxB; lane 3, cell extract from strain
DJ240-8-3 transformed with Ste2-44-PxB. Lanes 2 and 3 were
loaded with quantities of extract corresponding to 50 ng of P-lacta-
mase activity as determined by enzyme assay. Numbers at the
extreme left represent molecular mass markers (in kilodaltons).
TABLE 2. 3-Lactamase activities produced by transformants
containing Ste2-SPB fusions
,B-Lactamase activityb
Fusion ~ Yeaststrain'
eree
Cell TtlFusion
sYrXt
Secreted asciaed Totaicassociated
Ste2-98-SPB DJ240-8-3 125 160 285
DJ213-7-3 173 101 274
Ste2-235-SPB DJ240-8-3 277 230 507
DJ213-7-3 459 183 632
Ste2-369-SPB DJ240-8-3 505 213 718
DJ213-7-3 590 270 860
a Strains were DJ240-8-3 (stp22) and DJ213-7-3 (STP22).
b All enzyme activities shown are in picograms of P-lactamase per 106
organisms and are means of three replicate determinations carried out on at
least two independent transformants.
c The sums of activities in culture supernatants and cell extracts.
activity assays (Table 1). This implies that the cytoplasmi-
cally located ala, tethered to the membrane at the C termi-
nus of Ste2, retains full activity in yeast cells, a finding that
concurs with previous reports on expression of ,-lactamase-
containing fusion proteins in E. coli (8).
Extracts from transformants expressing Ste2-44-PxB did
contain a minor immunoreactive species of approximately 40
kDa, the expected size of this fusion protein. However, the
majority of immunoreactive material in these transformants
appeared to be mature-length 29-kDa 13la (Fig. 5, lane 3).
Since this apparent processing is not Kex2 dependent, it is
presumably occurring nonspecifically, before or after cell
breakage. The rather low activities observed suggested that
the Ste2 N-terminal fragment targets this fusion protein for
destruction by cytoplasmic surveillance mechanisms (4, 21).
P-Lactamase activities of Ste2-SPB fusions. The most util-
itarian target reporter gene fusion technologies are those
which, like complementary phoA and lacZ fusions in E. coli
(26), enable positive identification of domains of integral
membrane proteins located on either side of the membrane
in which the target protein is situated. With the aim of
developing such a reciprocal system in yeast cells, we
constructed three Ste2-SPB fusions in which the yeast killer
toxin signal sequence (S) is introduced between the Ste2
fragment and the PB reporter (Fig. 2G). In theory, if the
preceding Ste2 sequence dictates that the site of fusion is
cytoplasmic, as for the Ste2-235-SPB fusion (Fig. 3D), the S
signal peptide should act as an internal signal, leading to
exposure of the PB reporter on the lumenal face of the
secretory pathway. In Ste2-235-SPB and Ste2-369-SPB, the
introduction of S resulted in secretion of amounts of Pla by
transformants of strain DJ213-7-3 (STP22) or DJ240-8-3
(stp22) comparable to or higher than those obtained with
transformants possessing Ste2-98-PxB, Ste2-206-PxB, or
Ste2-259-PxB (Tables 1 and 2). Insertion of the signal
sequence, therefore, apparently led to reorientation of the
P-,la component of the resultant fusions from the cytoplas-
mic to the external compartment, as predicted. 13la activities
produced by the Ste2-SPB fusions did not appear to be
positively affected by the stp22-7 mutation, suggesting that
addition of the yeast killer toxin signal might improve the
efficiency of membrane insertion of fusions containing less
than the full complement of Ste2 membrane-spanning seg-
ments. When the same signal sequence was placed between
the Ste2 and P components of Ste2-98-PxB, the most effi-
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ciently expressed periplasmic fusion, secretion of fila de-
creased by 60 to 70%. Reorientation of the PB reporter to the
cytoplasm may have occurred (Fig. 3B).
DISCUSSION
This study describes the first demonstration of a gene
fusion approach to in vivo analysis of plasma membrane
protein topology in S. cerevisiae. While analysis of expres-
sion of direct fusions between Ste2 and Pla was largely
fruitless, apparently because of efficient destruction of the
fusion products, the introduction of a Kex2-cleavable bridge
(P) between the target protein and the reporter resulted in
accumulation of secreted pla from those fusions in which the
Ppla reporter is lumenal and therefore exposed to the active
site of Kex2 during passage through the Golgi. Although this
accumulated activity probably still represented only a few
percent of the total products of translation, 1la was released
at reproducible and readily assayable levels. Analysis of
these enzyme activities provided clear-cut, positive evi-
dence of the lumenal location of target reporter fusion sites
in all three Ste2 loops predicted to be external (fusions at 98,
206, and 259) and gave negative evidence for the location of
the two fusions sites at 235 and 369, predicted to be in
cytoplasmic domains.
In interpreting all such fusion experiments, the uncer-
tainty principle must be kept in mind: experimental obser-
vation inevitably perturbs the system observed. In gene
fusions, the reporter clearly has the potential to affect
membrane insertion of the attached target. Nevertheless,
our data suggest that the PxB reporter is relatively neutral in
its effects. It should be noted, however, that PxB fusions
introduce a short, hydrophobic, and potentially a-helical
stretch at the N terminus of P that consists of one to four Ala
residues derived from the PstI linkers followed by Ile Leu
(Fig. 1). The Phe-98 (DraI) and Ser-259 (ClaI) fusion sites
occur three and seven residues, respectively, before the
predicted C termini of transmembrane segments (Fig. 1).
The fusion replaces those residues with Ala Ala Ala Ile Leu,
potentially contributing to the fidelity of membrane insertion
of the products.
Use of the SP bridge, predicted to result in translocation of
the PB reporter from cytoplasmic sites of fusion to the
lumen, allowed positive identification of the cytoplasmic
fusion sites at 235 and 369. Secreted P-lactamase activities
were as high as with any of the lumenal PxB fusions lacking
the S signal. The marked reduction in secreted ,la observed
on insertion of S into the Ste2-98-PxB fusion was consistent
with the lumenal location of this fusion site indicated by the
PxB fusion data: the killer toxin signal, when preceded by
another signal sequence such as the second membrane-
spanning segment of Ste2, may function as a stop-transfer
sequence and thus reorient the P-1la reporter to the cyto-
plasm (Fig. 3B). Such interconversion of signal and stop-
transfer functions is sometimes inefficient (13), possibly
because of the more-stringent demands for hydrophobicity
postulated for stop-transfer segments and possibly because
of the dominant role normally played by flanking positive
charges in determining topogenicity (7, 37). S is reasonably
hydrophobic and does have two positively charged residues
near its N terminus but none at its C terminus, where they
might enhance its function as a stop-transfer sequence. It is,
therefore, probably much more efficient as a signal. An
alternative explanation of the effect of insertion of S on
expression of the Ste2-98-SPB fusion is that the two addi-
tional positively charged residues introduced into the first
extracellular loop of Ste2 (Fig. 1) decrease the efficiency of
insertion of the preceding membrane-spanning segment of
the Ste2 component and so decrease the amount of Kex2-
processed fla released. In practice, insertion of S allowed
positive identification of cytoplasmic fusion sites but only
corroborated external fusion sites. The results, however,
were internally consistent and entirely compatible with the
current topological model of Ste2 (9, 29).
The cell association of all products of the fusion at Val-44,just prior to the first transmembrane segment, showed that
no cryptic signallike function for this domain was detectable.
This is consistent with models in which the normal external
location of this domain is dictated by insertion of the first or
the first two transmembrane segments. Since the Phe-98
fusion gave the highest secreted activity, the first two
transmembrane segments apparently insert with normal to-
pology and reasonable efficiency and should suffice to exter-
nalize the N terminus. Direct testing of this inference and
testing of the first transmembrane segment in isolation are
needed to resolve this issue.
Verification of the in vivo topology of Ste2 was not the
only purpose of this investigation. Since Ste2 is one of the
few yeast plasma membrane proteins for which a relatively
unequivocal putative topology has been proposed, it was
chosen as a test system in which to establish the feasibility of
using the gene fusion techniques described in this paper for
other plasma membrane proteins. Success in this approach is
critically dependent not only on normal insertion of mem-
brane protein fusions in the ER, but also on their survival
during passage through the secretory apparatus. Subsequent
correct targeting and stability are required for detection of
fusions not subject to Kex2 cleavage, and failure at this level
presumably accounted for the failure of the "direct" Pla
fusion approach. Northern (RNA) blot analysis (not shown),
using the B fragment encoding Ila as probe, demonstrated
that steady-state transcript levels were comparable in pSte2-
98-PxB and p2OSPB transformants. However, the total ,la
activity produced from the Ste2-98-PxB fusion, the most
active of the protein constructs tested, was only 2% of the
activity produced by a p2OSPB transformant (Table 1). Since
p2OSPB differs from the Ste2 fusions only in lacking the Ste2
fragments (Fig. 2B), it appears that these Ste2 fragments are
responsible for loss of most of the translation product prior
to the point in the secretory pathway at which Kex2 cleavage
occurs. Destruction presumably results from action of the
salvage pathway and ER-associated degradation pathways
(2, 5, 30, 38), which appear to be efficient in recognizing
truncated Ste2 fragments. Only fusion Ste2-369-PxB, in
which only 63 amino acids were removed from the C
terminus of Ste2, appeared to be relatively stable as a
membrane-bound fusion protein. An equivalent C-terminal
deletion of Ste2 is stable and functional when expressed
from a YEp plasmid (25).
Several features of the killer toxin-,B-lactamase gene fu-
sion approach contribute to overcoming the problem of in
vivo fusion protein instability. First, the Kex2-mediated
liberation of the Pla reporter avoids destruction of fusion
proteins in the vacuole due to missorting or endocytosis.
Second, the stability of secreted Pla allows accumulation of
sufficient enzyme for detection. Third, the sensitivity of the
P-lactamase activity assay (10) is such that an expression
level of target-reporter fusion protein sufficient for 200
copies per cell per generation to reach the Golgi should be
sufficient for the data obtained to be interpretable. The
sensitivity of this technique may allow us to analyze the
topology of membrane proteins from higher eukaryotes
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2628 CARTWRIGHT AND TIPPER
heterologously expressed in S. cerevisiae. Recent advances
have also been made, both in vitro (37) and via gene fusion
technology in E. coli (7), in defining elements that control
topogenicity in membrane proteins. It would obviously be
advantageous to expand these studies into an in vivo eukary-
otic system. The indirect target-reporter fusion technique we
have developed may provide such an opportunity.
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